Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Employer
- Delft University of Technology (TU Delft)
- Eindhoven University of Technology (TU/e)
- University of Twente
- Wageningen University & Research
- Erasmus University Rotterdam
- European Space Agency
- University of Twente (UT)
- Maastricht University (UM)
- Vrije Universiteit Amsterdam (VU)
- Erasmus MC (University Medical Center Rotterdam)
- Utrecht University
- AMOLF
- ARCNL
- Eindhoven University of Technology
- KNAW
- Laigo Bio
- NLR
- Nature Careers
- Radboud University
- RiboPro B.V.
- Tilburg University
- University Medical Centre Groningen (UMCG)
- University of Amsterdam (UvA)
- 13 more »
- « less
-
Field
-
reduce the overall weight of wind turbines. By innovating ways to lower mechanical loads on critical components and optimizing material usage, we aim to pave the way for a truly circular wind energy sector
-
to extend the operational lifespan and reduce the overall weight of wind turbines. By innovating ways to lower mechanical loads on critical components and optimizing material usage, we aim to pave the way
-
the operational lifespan and reduce the overall weight of wind turbines. By innovating ways to lower mechanical loads on critical components and optimizing material usage, we aim to pave the way for a truly
-
to lower mechanical loads on critical components and optimizing material usage, we aim to pave the way for a truly circular wind energy sector. Your Role A key pillar of ECOWIND is bridging the gap between
-
capabilities, existing technology can only handle relatively small-scale problems. Information In the SymBi project (Exploiting Symmetries for Faster Bilevel Optimization Algorithms), we address this limitation
-
. In this project, we aim to prove the concept of hard/soft concrete composites. The research will include: Computational modelling and optimization of concrete architectures Experimental testing and
-
the Commencing CRISPR Commons project, funded by the Gates Foundation, which aims to establish a plant‑optimized, freedom‑to‑operate genome editing platform based on the ThermoCas9 nuclease. CRISPR/Cas systems
-
support optimization of patient care. Whether this is achievable depends on the reliability of an AI-model. Testing of AI is often done on small numbers, and AI-models are not equally useful in all
-
chip quality and reliability while optimizing overall test costs. The platform enables faster and more accurate diagnosis and yield learning, reduces in-field failures in various critical applications
-
-based optimization) for NP formulation design, targeting specific therapeutic outcomes such as blood-brain barrier permeability and tumour accumulation. Couple generative models with counterfactual